Neurostimulation Devices Market Share

The North America region neurostimulation devices market projected to hold the largest market share by the end of 2037. This can be accredited to the increasing prevalence of neurological disorders and the increasing level of the geriatric population in the region. According to statistics, in 2018, approximately 20 million US citizens experience some form of neuropathy, of which approximately 15% are individuals with brain impairment in US households. Further, the market is estimated to gain high growth during the forecast period, owing to the rising use of implantable neurostimulation devices to minimize pain and increasing initiatives to innovate medical devices in the region.